Skip to main
CME

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 15%
Buy 46%
Hold 31%
Sell 8%
Strong Sell 0%

Bulls say

CME Group is well positioned for durable fundamental growth because its 94% institutional ADV base is being supplemented by rising retail participation, stronger single stock futures adoption, and early weekend trading momentum in metals. Management’s ability to push through a 2% pricing increase in rates, while expanding Treasury clearing, Treasury Link, and compute futures, supports revenue growth, margin efficiency, and broader ecosystem monetization. With 29.7M August ADV, OI up about 200 bps Y/Y, and a 27% stake in S&P Dow Jones Indexes that should lift non-operating income, the business has multiple high-margin catalysts and limited evidence of meaningful competitive leakage.

Bears say

CME Group is exposed to slower Average Daily Volume growth and weaker Revenue per Contract trends, which could directly pressure top-line momentum and operating leverage. Its dependence on macro conditions such as short-term interest rate expectations, the yield curve, and widening credit spreads also makes earnings vulnerable, especially if lower interest rate cycles reduce hedging activity. Competitive threats from FMX, CBOE, ICE, and potential new entrants, combined with deal-integration risk and adverse regulatory changes, could erode market share and undermine revenue or OpEx guidance.

CME Group (CME) has been analyzed by 13 analysts, with a consensus rating of Buy. 15% of analysts recommend a Strong Buy, 46% recommend Buy, 31% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Buy based on their latest research and market trends.

According to 13 analysts, CME Group (CME) has a Buy consensus rating as of Oct 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $308.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $308.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.